Logo

This website is for healthcare professionals and other relevant decision makers only.

FREE EBOOK

The role of artificial intelligence in lung cancer diagnosis and screening

EN_Lung Cancer Screening_Cover_v2 (1)

One study showed that when utilizing data from electronic medical records and conventional chest x-rays, an AI algorithm was found to predict lung cancer over a 12-year period better than existing screening criteria and was associated with 31% fewer lung cancer cases being missed.

Learn about the potential of AI to address some of the most burdensome lung cancer screening and diagnostic challenges.

 

This eBook's highlights:

  • A look at various lung cancer screening strategies.

  • A closer look at research addressing the difficulties and complexities involved in lung cancer screening.

  • Exploring the impact of AI on identifying high-risk individuals, radiation dose reduction & image quality improvement, lung nodule detection, segmentation, and classification.

  • Discusses the hurdles to the adoption of AI in lung cancer screening and diagnosis and potential paths for future advancements.

© 2024 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the US, European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

Calantic is ISO 27001 certified. The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

PP-CALA-ALL-1007-1 July 2024